{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:17:27Z","timestamp":1792948647523,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05454-8","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T02:26:33Z","timestamp":1763951193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cross-Talk Between Tau O-GlcNAcylation and the Formation of the Early Driver of Neurodegeneration (Cis P-Thr231-Pro Tau) in Primary Cortical Neurons"],"prefix":"10.1007","volume":"63","author":[{"given":"Leila","family":"Aghababaee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Karimi-Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koorosh","family":"Shahpasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-4042","authenticated-orcid":false,"given":"Gholam Hossein","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"7","key":"5454_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","volume":"38","author":"ME Orr","year":"2017","unstructured":"Orr ME, Sullivan AC, Frost B (2017) A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol Sci 38(7):637\u2013648. https:\/\/doi.org\/10.1016\/j.tips.2017.03.011","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"5454_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.tem","volume":"30","author":"A Farhadi","year":"2019","unstructured":"Farhadi A, Vosough M, Zhang JS, Tahamtani Y, Shahpasand K (2019) A possible neurodegeneration mechanism triggered by diabetes. Trends Endocrinol Metab 30(10):692\u2013700. https:\/\/doi.org\/10.1016\/j.tem","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"5454_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4172\/2161-0460.1000443","volume":"8","author":"O Albayram","year":"2018","unstructured":"Albayram O, Angeli P, Bernstein E, Baxley S, Gao Z, Lu KP, Zhou XZ (2018) Targeting prion-like cis phosphorylated tau pathology in neurodegenerative diseases. J Alzheimers Dis Parkinsonism 8(3):443. https:\/\/doi.org\/10.4172\/2161-0460.1000443","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"6","key":"5454_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/NEN.0b013e3181772794","volume":"67","author":"D Iacono","year":"2008","unstructured":"Iacono D et al (2008) Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol 67(6):578\u2013589. https:\/\/doi.org\/10.1097\/NEN.0b013e3181772794","journal-title":"J Neuropathol Exp Neurol"},{"issue":"15","key":"5454_CR5","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1039\/b403634d","volume":"2","author":"LA Amos","year":"2004","unstructured":"Amos LA (2004) Microtubule structure and its stabilization. Org Biomol Chem 2(15):2153\u20132160. https:\/\/doi.org\/10.1039\/b403634d","journal-title":"Org Biomol Chem"},{"issue":"24","key":"5454_CR6","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1073\/pnas.1504081112","volume":"112","author":"H Kadavath","year":"2015","unstructured":"Kadavath H et al (2015) Tau stabilizes microtubules by binding at the interface between tubulin heterodimers. Proc Natl Acad Sci USA 112(24):7501\u20137506. https:\/\/doi.org\/10.1073\/pnas.1504081112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"5454_CR7","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","volume":"32","author":"K Shahpasand","year":"2012","unstructured":"Shahpasand K et al (2012) Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer\u2019s disease. J Neurosci 32(7):2430\u20132441. https:\/\/doi.org\/10.1523\/JNEUROSCI.5927-11.2012","journal-title":"J Neurosci"},{"key":"5454_CR8","doi-asserted-by":"publisher","unstructured":"Emadi S, Aghababaee L, Maghbooli M (2016) Serum concentration of beta amyloid peptide and the activity of angiotensin converting enzyme in Alzheimer\u2019s disease patients: search for a potential biomarker. IJRMS 4(2): 421\u2013427. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20160289","DOI":"10.18203\/2320-6012.ijrms20160289"},{"issue":"9","key":"5454_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672. https:\/\/doi.org\/10.1038\/nrn2194","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"5454_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17(1):5\u201321. https:\/\/doi.org\/10.1038\/nrn","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"5454_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/bies","volume":"25","author":"KP Lu","year":"2003","unstructured":"Lu KP, Liou YC, Vincent I (2003) Proline-directed phosphorylation and isomerization in mitotic regulation and in Alzheimer\u2019s disease. Bioessays 25(2):174\u2013181. https:\/\/doi.org\/10.1002\/bies","journal-title":"Bioessays"},{"issue":"10","key":"5454_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.jalz.2016.02.011","volume":"12","author":"CX Gong","year":"2016","unstructured":"Gong CX, Liu F, Iqbal K (2016) O-GlcNAcylation: a regulator of tau pathology and neurodegeneration. Alzheimers Dement 12(10):1078\u20131089. https:\/\/doi.org\/10.1016\/j.jalz.2016.02.011","journal-title":"Alzheimers Dement"},{"key":"5454_CR13","doi-asserted-by":"publisher","unstructured":"Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 7;91(12): 5562\u20135566. https:\/\/doi.org\/10.1073\/pnas.91.12.5562","DOI":"10.1073\/pnas.91.12.5562"},{"key":"5454_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid Med Cell Longev 2013:316523. https:\/\/doi.org\/10.1155\/2013\/316523","journal-title":"Oxid Med Cell Longev"},{"key":"5454_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/2013\/316523","volume":"74","author":"D Allan Butterfield","year":"2014","unstructured":"Allan Butterfield D (2014) The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequelain brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic Biol Med 74:157\u2013174. https:\/\/doi.org\/10.1155\/2013\/316523","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5454_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00004647-200002000-00019","volume":"20","author":"PF Stahel","year":"2000","unstructured":"Stahel PF et al (2000) Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 20(2):369\u2013380. https:\/\/doi.org\/10.1097\/00004647-200002000-00019","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"5454_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/neu.1996.13.557","volume":"13","author":"Y Chen","year":"1996","unstructured":"Chen Y et al (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13(10):557\u2013568. https:\/\/doi.org\/10.1089\/neu.1996.13.557","journal-title":"J Neurotrauma"},{"issue":"4","key":"5454_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3233\/JAD-150820","volume":"51","author":"M Elahi","year":"2016","unstructured":"Elahi M et al (2016) Region-specific vulnerability to oxidative stress, neuroinflammation, and tau hyperphosphorylation in experimental diabetes mellitus mice. J Alzheimers Dis 51(4):1209\u20131224. https:\/\/doi.org\/10.3233\/JAD-150820","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"5454_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1590\/1980-57642015DN92000003","volume":"9","author":"M Matioli","year":"2015","unstructured":"Matioli M et al (2015) Mechanisms linking brain insulin resistance to Alzheimer\u2019s disease. Dement Neuropsychol 9(2):96\u2013102. https:\/\/doi.org\/10.1590\/1980-57642015DN92000003","journal-title":"Dement Neuropsychol"},{"key":"5454_CR20","doi-asserted-by":"publisher","unstructured":"Braak H et al (19860 Occurrence of neuropil threads in the senile human brain and in Alzheimer\u2019s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 65(3): 351\u2013355. https:\/\/doi.org\/10.1016\/0304-3940(86)90288-0","DOI":"10.1016\/0304-3940(86)90288-0"},{"key":"5454_CR21","doi-asserted-by":"publisher","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E Kopke","year":"1993","unstructured":"Kopke E et al (1993) Grundke-Iqbal, microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374\u201324384. https:\/\/doi.org\/10.1016\/S0021-9258(20)80536-5","journal-title":"J Biol Chem"},{"issue":"2","key":"5454_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0006-8993(92)91476-u","volume":"597","author":"H Ksiezak-Reding","year":"1992","unstructured":"Ksiezak-Reding H et al (1992) Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res 597(2):209\u2013219. https:\/\/doi.org\/10.1016\/0006-8993(92)91476-u","journal-title":"Brain Res"},{"issue":"12","key":"5454_CR23","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/cn500148z","volume":"5","author":"MDC C\u00e1rdenas-Aguayo","year":"2014","unstructured":"C\u00e1rdenas-Aguayo MDC et al (2014) (2014) The role of tau Oligomers in the onset of Alzheimer\u2019s disease neuropathology. ACS Chem Neurosci 5(12):1178\u20131191. https:\/\/doi.org\/10.1021\/cn500148z","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"5454_CR24","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA et al (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J 26(5):1946\u20131959. https:\/\/doi.org\/10.1096\/fj.11-199851","journal-title":"FASEB J"},{"issue":"2","key":"5454_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4161\/pri.22849","volume":"7","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Zhou XZ, Lu KP (2013) Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies. Prion 7(2):117\u2013120. https:\/\/doi.org\/10.4161\/pri.22849","journal-title":"Prion"},{"issue":"7","key":"5454_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2174\/1566524011313070001","volume":"13","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Zhou XZ, Lu KP (2013) Distinct functions of cis and trans phosphorylated tau in Alzheimer\u2019s disease and their therapeutic implications. Curr Mol Med 13(7):1098\u20131109","journal-title":"Curr Mol Med"},{"key":"5454_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","volume":"149","author":"K Nakamura","year":"2012","unstructured":"Nakamura K et al (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer\u2019s disease. Cell 149:232\u2013244. https:\/\/doi.org\/10.1016\/j.cell.2012.02.016","journal-title":"Cell"},{"key":"5454_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/21650","volume":"399","author":"PJ Lu","year":"1999","unstructured":"Lu PJ et al (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399:784\u2013788. https:\/\/doi.org\/10.1038\/21650","journal-title":"Nature"},{"key":"5454_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s1097-2765(05)00083-3","volume":"6","author":"XZ Zhou","year":"2000","unstructured":"Zhou XZ et al (2000) Pin1- dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 6:873\u2013883. https:\/\/doi.org\/10.1016\/s1097-2765(05)00083-3","journal-title":"Mol Cell"},{"key":"5454_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature01832","volume":"424","author":"YC Liou","year":"2003","unstructured":"Liou YC et al (2003) Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424:556\u2013561. https:\/\/doi.org\/10.1038\/nature01832","journal-title":"Nature"},{"key":"5454_CR31","doi-asserted-by":"publisher","unstructured":"Kondo A et al (2015) Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 23;523(7561): 431\u2013436, https:\/\/doi.org\/10.1038\/nature14658","DOI":"10.1038\/nature14658"},{"key":"5454_CR32","doi-asserted-by":"publisher","unstructured":"Lu KP et al (2016) Potential of the antibody against cis\u2013phosphorylated tau in the early diagnosis, treatment, and prevention of Alzheimer disease and brain injury. JAMA Neurol 1;73(11): 1356\u20131362. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2027","DOI":"10.1001\/jamaneurol.2016.2027"},{"key":"5454_CR33","doi-asserted-by":"publisher","unstructured":"Albayram O et al (2017) Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae. Nat Communications 8:1000. https:\/\/doi.org\/10.1038\/s41467-017-01068-4","DOI":"10.1038\/s41467-017-01068-4"},{"key":"5454_CR34","doi-asserted-by":"publisher","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","volume":"288","author":"EE Congdon","year":"2013","unstructured":"Congdon EE et al (2013) Antibody uptake into neurons occurs primarily via clathrin-dependent Fc\u03b3 receptor endocytosis and is a prerequisite for acute tau protein clearance. J Biol Chem 288:35452\u201335465. https:\/\/doi.org\/10.1074\/jbc.M113.491001","journal-title":"J Biol Chem"},{"key":"5454_CR35","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL et al (2010) Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Aca Sci USA 107:19985\u201319990. https:\/\/doi.org\/10.1073\/pnas.1014074107","journal-title":"Proc Natl Aca Sci USA"},{"issue":"3","key":"5454_CR36","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/acschemneuro","volume":"10","author":"R Naserkhaki","year":"2019","unstructured":"Naserkhaki R et al (2019) Cis pT231-tau drives neurodegeneration in bipolar disorder. ACS Chem Neurosci 10(3):1214\u20131221. https:\/\/doi.org\/10.1021\/acschemneuro","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5454_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13578-016-0124-4","volume":"6","author":"O Albayram","year":"2016","unstructured":"Albayram O et al (2016) Function and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegeneration. Cell Biosci 6(1):4\u20139. https:\/\/doi.org\/10.1186\/s13578-016-0124-4","journal-title":"Cell Biosci"},{"issue":"1","key":"5454_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnen\/nlv001","volume":"75","author":"NM Kanaan","year":"2016","unstructured":"Kanaan NM et al (2016) Characterization of early pathological tau conformations and phosphorylation in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 75(1):19\u201334. https:\/\/doi.org\/10.1093\/jnen\/nlv001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"5454_CR39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","volume":"8","author":"KP Lu","year":"2007","unstructured":"Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signaling and disease. Nat Rev Mol Cell Biol 8(11):904\u2013916. https:\/\/doi.org\/10.1038\/nrm2261","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5454_CR40","doi-asserted-by":"crossref","unstructured":"Li HL et al (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing _-catenin, a mechanism involved in Alzheimer\u2019s neurodegeneration. PNAS 104(9): 3591\u20133596. 10.1073_pnas.0609303104","DOI":"10.1073\/pnas.0609303104"},{"key":"5454_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-2010-091279","volume":"21","author":"HH Wang","year":"2010","unstructured":"Wang HH et al (2010) Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. J of Alzheimer\u2019s Dis 21:167\u2013179. https:\/\/doi.org\/10.3233\/JAD-2010-091279","journal-title":"J of Alzheimer\u2019s Dis"},{"issue":"8","key":"5454_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nchembio.96","volume":"4","author":"SA Yuzwa","year":"2008","unstructured":"Yuzwa SA et al (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4(8):483\u2013490. https:\/\/doi.org\/10.1038\/nchembio.96","journal-title":"Nat Chem Biol"},{"key":"5454_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuropharm.2013.11.025","volume":"79","author":"DL Graham","year":"2014","unstructured":"Graham DL et al (2014) Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology 79:307\u2013313. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.025","journal-title":"Neuropharmacology"},{"issue":"4","key":"5454_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/NChemBio.797","volume":"8","author":"SA Yuzwa","year":"2012","unstructured":"Yuzwa SA et al (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 8(4):393\u2013399. https:\/\/doi.org\/10.1038\/NChemBio.797","journal-title":"Nat Chem Biol"},{"issue":"7","key":"5454_CR45","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K (2017) Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol 18(7):452\u2013465. https:\/\/doi.org\/10.1038\/nrm.2017.22","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5454_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","volume":"2","author":"C Butkinaree","year":"1800","unstructured":"Butkinaree C et al (1800) (2010) O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 2:96\u2013106. https:\/\/doi.org\/10.1016\/j.bbagen.2009.07.018","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"5454_CR47","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1074\/jbc.M113.512814","volume":"289","author":"Y Skorobogatko","year":"2014","unstructured":"Skorobogatko Y et al (2014) O-linked beta-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles. J Biol Chem 289(6):3602\u201312. https:\/\/doi.org\/10.1074\/jbc.M113.512814","journal-title":"J Biol Chem"},{"key":"5454_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)67706-9","author":"S Marshall","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger RR (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(19)67706-9","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"5454_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbalip.2006.04.007","volume":"1761","author":"NE Zachara","year":"2006","unstructured":"Zachara NE, Hart GW (2006) Cell signaling, the essential role of O-GlcNAc. Biochim Biophys Acta 1761(5\u20136):599\u2013617. https:\/\/doi.org\/10.1016\/j.bbalip.2006.04.007","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"5454_CR50","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/acs.chemrev.0c00884","volume":"121","author":"J Ma","year":"2012","unstructured":"Ma J, Wu C, Hart GW (2012) Analytical and biochemical perspectives of protein O-GlcNAcylation. Chem Rev 121(3):1513\u20131581. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00884","journal-title":"Chem Rev"},{"key":"5454_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-201450","volume":"81","author":"D Pan","year":"2012","unstructured":"Pan D et al (2012) Thiamme2-G, a novel O-GlcNAcase inhibitor, reduces tau hyperphosphorylation and rescues cognitive impairment in mice. J Alzheimer\u2019s Dis 81:273\u2013286. https:\/\/doi.org\/10.3233\/JAD-201450","journal-title":"J Alzheimer\u2019s Dis"},{"key":"5454_CR52","doi-asserted-by":"publisher","unstructured":"Rexach JE et al (2008) Chemical approaches to understanding O-GlcNAc glycosylation in the brain. Nat Chem Biol 4(2). https:\/\/doi.org\/10.1038\/nchembio.68","DOI":"10.1038\/nchembio.68"},{"key":"5454_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cbpa.2019.09.001","volume":"53","author":"DT King","year":"2019","unstructured":"King DT et al (2019) Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc) processing enzymes. Curr Opin Chem Biol 53:131\u2013144. https:\/\/doi.org\/10.1016\/j.cbpa.2019.09.001","journal-title":"Curr Opin Chem Biol"},{"key":"5454_CR54","doi-asserted-by":"publisher","unstructured":"Hanger DP, Nobel W (2011) Functional implications of glycogen synthase kinase- 3-mediated tau phosphorylation. Int J Alzheimers Dis 352805. https:\/\/doi.org\/10.4061\/2011\/352805","DOI":"10.4061\/2011\/352805"},{"issue":"1","key":"5454_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbrc.2008.07.101","volume":"375","author":"C Yu","year":"2008","unstructured":"Yu C et al (2008) O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau. Biochem Biophys Res Commun 375(1):59\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.101","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"5454_CR56","doi-asserted-by":"publisher","first-page":"e35277","DOI":"10.1371\/journal.pone.0035277","volume":"7","author":"Y Yu","year":"2012","unstructured":"Yu Y et al (2012) Differential effects of an OGlcNAcase inhibitor on tau phosphorylation. PLoS One 7(4):e35277. https:\/\/doi.org\/10.1371\/journal.pone.0035277","journal-title":"PLoS One"},{"issue":"8","key":"5454_CR57","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1111\/j.1460-9568.2006.04735.x","volume":"23","author":"X Li","year":"2006","unstructured":"Li X et al (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23(8):2078\u20132086. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04735.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"5454_CR58","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/brain\/awp099","volume":"132","author":"F Liu","year":"2009","unstructured":"Liu F et al (2009) Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease. Brain 132(7):1820\u20131832. https:\/\/doi.org\/10.1093\/brain\/awp099","journal-title":"Brain"},{"issue":"2","key":"5454_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12017-019-08584-0","volume":"22","author":"J Park","year":"2020","unstructured":"Park J et al (2020) OGlcNAcylation as a therapeutic target for Alzheimer\u2019s disease. Neuromolecular Med 22(2):171\u2013193. https:\/\/doi.org\/10.1007\/s12017-019-08584-0","journal-title":"Neuromolecular Med"},{"issue":"2","key":"5454_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0304-4165(02)00477-4","volume":"1619","author":"T Lefebvre","year":"2003","unstructured":"Lefebvre T et al (2003) Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins- a role in nuclear localization. Biochim Biophys Acta 1619(2):167\u2013176. https:\/\/doi.org\/10.1016\/s0304-4165(02)00477-4","journal-title":"Biochim Biophys Acta"},{"issue":"19","key":"5454_CR61","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1073\/pnas.1200425109","volume":"109","author":"JF Alfaro","year":"2012","unstructured":"Alfaro JF et al (2012) Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci USA 109(19):7280\u20135. https:\/\/doi.org\/10.1073\/pnas.1200425109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5454_CR62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neurobiolaging.2010.05.018","volume":"33","author":"SL Ma","year":"2012","unstructured":"Ma SL et al (2012) A PIN1 polymorphism that prevents its suppression by AP4 associates with delayed onset of Alzheimer\u2019s disease. Neurobiol Aging 33(4):804\u2013813. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.018","journal-title":"Neurobiol Aging"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05454-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:09:02Z","timestamp":1764180542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05454-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5454"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05454-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"1 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"158"}}